BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21062727)

  • 1. Individualizing mesothelioma treatment: small steps into a brighter future.
    Garland L; Flores R; Tsao A
    Clin Lung Cancer; 2010 Nov; 11(6):371-3. PubMed ID: 21062727
    [No Abstract]   [Full Text] [Related]  

  • 2. Combat against cancer with science and medicine.
    Chow LW; Toi M
    Expert Opin Investig Drugs; 2010 Apr; 19 Suppl 1():S3-4. PubMed ID: 20374027
    [No Abstract]   [Full Text] [Related]  

  • 3. [Personalized, targeted treatment of non-small cell lung cancer].
    Wolf J
    Dtsch Med Wochenschr; 2011 Mar; 136(10):480-5. PubMed ID: 21365525
    [No Abstract]   [Full Text] [Related]  

  • 4. Biology and management of malignant pleural mesothelioma.
    Zucali PA; Giaccone G
    Eur J Cancer; 2006 Nov; 42(16):2706-14. PubMed ID: 16989994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesothelioma: path to multimodality treatment.
    Su S
    Semin Thorac Cardiovasc Surg; 2009; 21(2):125-31. PubMed ID: 19822284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of malignant pleural mesothelioma.
    West SD; Lee YC
    Clin Chest Med; 2006 Jun; 27(2):335-54. PubMed ID: 16716822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Individualized treatment of breast cancer].
    Eucker J; Possinger K
    Dtsch Med Wochenschr; 2011 Mar; 136(10):486-91. PubMed ID: 21365526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trials in malignant pleural mesothelioma in Australasia.
    Nowak AK
    Lung Cancer; 2005 Jul; 49 Suppl 1():S113-6. PubMed ID: 15950790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the systemic therapy of malignant pleural mesothelioma.
    Fennell DA; Gaudino G; O'Byrne KJ; Mutti L; van Meerbeeck J
    Nat Clin Pract Oncol; 2008 Mar; 5(3):136-47. PubMed ID: 18227828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of malignant pleural mesothelioma--present status and future view].
    Yano T; Morodomi Y; Ito K; Miura N; Takenaka T; Kawano D; Shoji F; Maehara Y
    Fukuoka Igaku Zasshi; 2008 Apr; 99(4):74-9. PubMed ID: 18646592
    [No Abstract]   [Full Text] [Related]  

  • 11. An overview of chemotherapy for mesothelioma.
    Krug LM
    Hematol Oncol Clin North Am; 2005 Dec; 19(6):1117-36, vii. PubMed ID: 16325127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ['Malignant peritoneal mesothelioma': a condition difficult to diagnose].
    van der Valk FM; van Leeuwen J
    Ned Tijdschr Geneeskd; 2012; 156(15):A4269. PubMed ID: 22495008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic options in malignant pleural mesothelioma].
    Serke M; Loddenkemper R
    Pneumologie; 2005 May; 59(5):337-48. PubMed ID: 15902599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Malignant peritoneal mesothelioma revealed by small bowel obstruction].
    Béchade D; Algayres JP; Baranger B; Arborio M; Louvet C; Krulik M; Bili H; Coutant G; Daly JP
    Gastroenterol Clin Biol; 2000 Dec; 24(12):1237-40. PubMed ID: 11173742
    [No Abstract]   [Full Text] [Related]  

  • 15. [New approaches for mesothelioma].
    Morère JF
    Rev Pneumol Clin; 2004 Nov; 60(5 Pt 3):4S57-4S60. PubMed ID: 15687997
    [No Abstract]   [Full Text] [Related]  

  • 16. Multimodality therapy in mesothelioma: role of chemotherapy.
    Vogelzang NJ
    Thorac Surg Clin; 2004 Nov; 14(4):531-42. PubMed ID: 15559060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The end of chemotherapy in renal cell carcinoma: for much but not for all.
    Iacovelli R; Raimondi C; Palazzo A
    Am J Clin Oncol; 2010 Oct; 33(5):522-3. PubMed ID: 20924226
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemoimmunotherapy: an emerging strategy for the treatment of malignant mesothelioma.
    McCoy MJ; Nowak AK; Lake RA
    Tissue Antigens; 2009 Jul; 74(1):1-10. PubMed ID: 19422663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Updated recommendations on systemic treatment of non-small cell lung cancer and malignant pleural mesothelioma].
    Jassem J; Biernat W; Drosik K; Dziadziuszko R; Kordek R; Kozielski J; Kowalski DM; Krzakowski M; Nikliński J; Olszewski W; Orłowski T; Ramlau R; Roszkowski-Śliż K; Rzyman W
    Pneumonol Alergol Pol; 2010; 78(6):418-31. PubMed ID: 21077034
    [No Abstract]   [Full Text] [Related]  

  • 20. Future developments in the management of malignant pleural mesothelioma.
    Zucali PA; De Vincenzo F; Simonelli M; Santoro A
    Expert Rev Anticancer Ther; 2009 Apr; 9(4):453-67. PubMed ID: 19374599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.